G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
22.50
-2.50 (-10.00%)
Nov 20, 2026, 1:30 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 1.55 billion as of November 20, 2026. It is the 29,937th most valuable company in the world and the 1,692nd biggest in Taiwan. Its market cap has decreased by 45.32% in one year.
Market Cap
1.55B
Enterprise Value
1.22B
Revenue
170.13M
Global Rank
Country Rank
#1,692 Taiwan
PE Ratio
27.89
ChartMarket Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has decreased from 2.62B to 1.55B, a decrease of -40.88%. That is a compound annual growth rate of -2.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.55B | -43.36% |
| Dec 31, 2025 | 2.73B | -18.14% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 2.22B |
| Syngen Biotech | 2.15B |
| GlycoNex Incorporation | 2.09B |
| HeXun Biosciences | 2.01B |
| 3D Global Biotech | 1.87B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.73B |
| U-Neuron Biomedical | 1.59B |
| GenMont Biotech Incorporation | 1.42B |